Stockwinners Market Radar for September 13, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:09 EDT Cathie Wood's ARK Investment sold 51.2K shares of Tesla today

20:08 EDT Cathie Wood's ARK Investment bought 148.5K shares of Beam Therapeutics today

19:17 EDT Wingstop exec sells $1.1M in common stock - In a regulatory filing, Wingstop disclosed that its SVP of Corp. Restaurants, Donnie Upshaw sold 6.7K shares of common stock on September 11th in a total transaction size of $1.1M.

18:46 EDT PureCycle Technologies declares force majeure due to storm impact on Ironton - In a regulatory 8-K filing, PureCycle Technologies announced it is declaring force majeure given the uncertainties over the company's ability to achieve remaining milestones as a result of Ironton Facility being negatively impacted by severe thunderstorm which knocked out power in southern Ohio for extended period of time. Reference Link

18:35 EDT Qualcomm CTO Thompson sells 27,962 common shares - In a regulatory filing, Qualcomm CTO James Thompson disclosed the sale of 27,962 common shares of the company on September 13 at a price of $113.2286 per share.

18:03 EDT T-Mobile exec sells $2.1M in common stock - In a regulatory filing, T-Mobile disclosed that its Consumer Group President Jon Freier sold 15K shares of common stock on September 11th in a total transaction size of $2.1M.

17:34 EDT Vital Energy sees FY24 production 86-90 MBOE/d - Sees FY24 pro forma production 109-115 MBOE/d. Sees FY24 incurred capital expenditures $650M-$710M. Sees FY24 pro forma incurred capital expenditures $750M-$850M. Sees FY24 average rig count three. Sees FY24 pro forma average rig count 3.5. The company said, "Vital Energy expects to realize operational synergies associated with a larger, consolidated Delaware position and the ability to optimize activity levels between the Midland and Delaware basins. The Company plans to prioritize returns and Free Cash Flow generation and expects to invest $100 - $125 million in the newly acquired assets in 2024, representing less than half of the previous operators' activity levels. Through the addition of recent hedges, the Company has significantly derisked its 2024 Free Cash Flow and leverage outlook, underpinning acquisition cash flows and returns. Vital Energy has hedged approximately 75% of expected 2024 pro forma oil volumes at an average price of approximately $75 per barrel WTI."

17:32 EDT Vital Energy sees Q4 production 83.3-87.3 MBOE/d - Sees Q4 pro forma production 98-102 MBOE/d. Sees Q4 incurred capital expenditures $165M-$180M. Sees Q4 pro forma incurred capital expenditures $195M-$210M. Sees Q4 average rig count of three. Sees Q4 pro forma average rig count 3.5.

17:25 EDT Imax and Prime Focus Technologies expand strategic streaming relationship - Imax and Prime Focus Technologies, or PFT, the creator of AI-powered technology solutions for the Media and Entertainment industry, announced plans to expand their strategic relationship beyond theatrical and into the streaming ecosystem. Imax will expand access to its Stream Smart technology to PFT customers across Europe, Asia, and Australia. The expanded partnership will increase the global availability of Stream Smart. PFT and its parent company, DNEG, provide a full suite of technology and creative solutions, including Imax post-production and 3D mastering. Imax and DNEG joined forces in 2022 for post-production. This extended partnership will build upon the theatrical relationship between Imax and DNEG to develop a comprehensive video optimization solution.

16:55 EDT Iris Energy reports FY23 Bitcoin mining revenue $75.5M vs $59M last year - Reports FY23: Record 3,259 Bitcoin mined, as compared to 1,399 Bitcoin mined in fiscal year 2022, primarily driven by growth in operating hashrate; Electricity costs of $35.8 million, as compared to $11.0 million in fiscal year 2022, primarily driven by growth in operating hashrate, with 3 new sites commissioned during the year; Other costs of $38.3 million, as compared to $21.8 million in fiscal year 2022. Cost base reflects materially expanded business with growth beyond existing 5.6 EH/s Net loss after income tax of $171.9 million, as compared to a $419.8 million loss in fiscal year 2022. The decrease in net loss after income tax primarily reflects impact of non-cash mark-to-market of convertible instruments converted into equity at IPO during the prior period Non-cash impairment charge of $105.2 million recorded in fiscal year 2023, primarily relating to the limited-recourse financing SPVs and impairment of mining hardware. The limited-recourse financing SPVs were deconsolidated on February 3, 2023 with the appointment of the Receiver Adjusted EBITDA of $1.4 million as compared to $26.2 million in fiscal year 20221 $68.9 million cash and cash equivalents as of June 30, 2023 and no debt facilities. "FY23 was a transformational year for Iris Energy", stated Daniel Roberts, Co-Founder and Co-Chief Executive Officer of Iris Energy. "We increased our operating hashrate to 5.6 EH/s but importantly also expanded our power capacity to an industry-leading 760MW, thereby activating an expansion pathway to 30 EH/s. We also remain excited by our next-gen compute and generative AI strategy, providing an additional potential growth area for the Company."

16:53 EDT Amazon debuts generative AI tools to help sellers list and shoppers purchase - Mary Beth Westmoreland, Vice President, Worldwide Selling Partner Experience for Amazon, blogged, in part, earlier: "New AI capabilities make it easier for sellers to write engaging, effective product listings, and help shoppers find what they are looking for. Generative artificial intelligence is helping people tackle tasks like building spreadsheets, captioning images, and writing essays, poems, and presentations. Now, Amazon is using the latest advancements in AI to dramatically improve the listing creation and management experience for sellers. A new set of generative AI capabilities will simplify how Amazon sellers create more thorough and captivating product descriptions, titles, and listing details. These new capabilities will make it faster and easier for sellers to list new products as well as enrich existing listings, helping customers more confidently make purchase decisions...Creating compelling product titles, bullet points, and descriptions has previously required significant work for sellers. Amazon is making new generative AI capabilities available to sellers to simplify that process, reducing the need to enter many pieces of specific product data to just one step. The new capabilities use large language models, LLMs, a type of machine learning model specifically trained on large amounts of data that can recognize, summarize..." Reference Link

16:38 EDT Kiromic BioPharma to switch trading from Nasdaq to OTC pink sheets - Kiromic BioPharma announced that on September 12, it received formal notice from the NASDAQ Stock Market that the company's common stock has been suspended from trading on the Nasdaq Capital Market effective September 14, due to failure to demonstrate compliance with Listing Rule 5550(b). The company's common stock will be quoted on the Pink Sheets platform operated by OTC Markets and will commence trading on September 14 at the market open under the "KRBP" ticker symbol while it pursues an uplisting to the OTCQB exchange. While the reporting requirements are different on the OTC Pink Sheets, the company will continue to file regular financial statements and provide updates consistent with Nasdaq requirements and past practices.

16:31 EDT HealthStream announces up to $10M share repurchase program - HealthStream announced that its board of directors has approved a new share repurchase program for the company's common stock, under which the company may repurchase up to $10M of outstanding shares of common stock. Pursuant to the authorization, repurchases may be made from time to time in the open market, including under a Rule 10b5-1 plan, through privately negotiated transactions, or otherwise. In addition, any repurchases under the authorization will be subject to prevailing market conditions, liquidity and cash flow considerations, applicable securities laws requirements, and other factors. The share repurchase program will terminate on the earlier of March 31, 2024 or when the maximum dollar amount has been expended. The share repurchase program does not require the company to acquire any amount of shares and may be suspended or discontinued at any time.

16:31 EDT Semtech says Q2 financials 'assuming company can continue as going concern' - In the Liquidity section of the company's 10-Q filing, Semtech stated: "The accompanying interim unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. Management evaluated whether there are any conditions and events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern over the next twelve months from the issuance of the accompanying interim unaudited condensed consolidated financial statements. Compliance with the Company's leverage and interest expense coverage financial covenants is measured quarterly based upon the Company's performance over the most recent four quarters, and compliance with the liquidity covenant is measured as of the last day of each monthly accounting period. As of July 30, 2023, the Company was in compliance with the financial covenants in the Credit Agreement. In response to adverse market demand conditions, the Company has taken actions to reduce expenses to preserve cash and maintain compliance with its financial covenants. In the absence of additional actions, the Company may not maintain compliance with the financial covenants over the next twelve months from the issuance of the accompanying interim unaudited condensed consolidated financial statements, which noncompliance would raise substantial doubt about the Company's ability to continue as a going concern. Failure to meet the covenant requirements in the Credit Agreement would constitute an event of default under the Credit Agreement and there is no certainty the Company would be able to obtain waivers or amendments with the requisite lenders party thereto in order to maintain compliance."

16:25 EDT Scinai Immunotherapeutics announces results from preclinical NanoAbs study - Scinai Immunotherapeutics (SCNI) announced results in a preclinical study of Scinai's anti-interleukin 17, or IL-17, NanoAbs as a treatment for plaque psoriasis. Scinai's NanoAbs are alpaca-derived recombinant variable domain of heavy-chain-only antibodies and are also known as nanobodies or VHH antibodies. The NanoAbs were tested in a 3D biologic skin model constructed out of a scaffold mounted with various skin cells to generate layers that mimic the structure of human skin and induced to express plaque psoriasis. Upon introduction of NanoAbs into the model, standard molecular markers for psoriasis that are overexpressed in the disease were downregulated and outer skin layers regained normal appearance. These results suggest NanoAbs' therapeutic potential to relieve symptoms of plaque psoriasis. In earlier laboratory tests the NanoAbs showed not only high affinity to all three IL-17 isoforms relevant for psoriasis, but also significant neutralization of these isoforms in tissue cultures. IL-17 plays a major role in the development of plaque psoriasis and is the molecular target of several recently launched biological treatments, mainly monoclonal antibodies, or mAbs, such as Cosentyx (NVS) and Taltz (LLY), both of which target IL-17A. Research shows that targeting IL-17F isoform in addition to IL-17A provides higher efficacy in treating plaque psoriasis. The recently launched Bimzelx was the first mAb targeting both IL-17A and F to be approved by the by the European Medicines Agency, or EMA. MoonLake Immunotherapeutics (MLTX) is also developing a nanobody targeting both IL-17A and F. Last year, MoonLake reported superior results vs. Cosentyx in a phase 2 plaque psoriasis clinical trial. All the above-mentioned antibodies, indicated only for moderate to severe psoriasis patients, are administered by subcutaneous injection for systemic drug distribution and carry risk of considerable side effects. These drugs are also expensive as they require chronic, life long, bi-weekly injections, each at a cost of several thousand dollars. Mild psoriasis, which accounts for 50% of plaque psoriatic patients, unfortunately has no safe and affordable biological drug available. Experience shows that even the 28% of patients with moderate plaque psoriasis tend to avoid or delay onset of these biological treatments due to the associated risks. Conversely, Scinai's NanoAbs are designed to be administered locally to the dermis and are engineered to degrade in a way that should prevent systemic side effects. Results of this recent study suggest the potential for a highly efficacious, specific, yet safer and more convenient treatment for the large and underserved population of mild to moderate plaque psoriasis patients. The NanoAb, exclusively licensed to Scinai, was discovered by Professor Dirk Gorlich, director at the Max Planck Institute for Multidisciplinary Sciences and was tested for neutralization at the laboratory of Professor Matthias Dobbelstein at University Medical Center Gottingen (UMG). Gorlich and Dobbelstein are Scinai's lead collaborators for development of a pipeline of NanoAb-based inflammation and immunology biological therapeutics for the treatment of autoimmune and infectious diseases such as psoriasis, psoriatic arthritis, asthma, wet AMD and COVID-19. Scinai recently started to evaluate the anti-IL-17 NanoAbs in a full human skin model induced for plaque psoriasis to evaluate the effective dose and schedule of treatment, with in-vivo animal studies anticipated in early 2024.

16:19 EDT W. R. Berkley declares special dividend of 50c per share - W. R. Berkley announced that its Board of Directors has declared a special cash dividend on its common stock of 50 cents per share to be paid on October 4, 2023 to stockholders of record at the close of business on September 25, 2023. Together with the 50 cents per share special dividend that was paid on January 24, 2023, this will bring special cash dividends paid during 2023 to $1.00 per share.

16:16 EDT Robinhood reports August assets under custody $89.7B, down 5% - Robinhood reported selected monthly operating data for August. Net cumulative funded accounts, or NCFA, at the end of August were 23.2M, up approximately 30,000 from July. Monthly active users, or MAU, decreased to 10.6M in August, down approximately 400,000 from July. Assets under custody, or AUC, at the end of August were $89.7B, down 5% from July. Net deposits were $1.6B in August, translating to a 20% annualized growth rate relative to July AUC. Over the last twelve months, net deposits were $17.6B, translating to an annual growth rate of 25% relative to August 2022 AUC. Trading volumes in August were slightly higher for options and lower for equities and crypto compared to July. Equity notional trading volumes were $59.8B. Options contracts traded were 107.3M. Crypto notional trading volumes were $2.2B. Margin Balances at the end of August were $3.5B, up 3% from July. Cash sweep balances at the end of August were $13.3B, up $0.6B from the end of July.

16:10 EDT Trinity Capital increases Q3 dividend to 49c, declares 5c supplemental dividend - Trinity Capital declared a cash dividend of 54c per share with respect to the quarter ending September 30, 2023, consisting of a regular quarterly dividend of 49c per share and a supplemental cash dividend of 5c per share. The dividend represents an increase of 2.1% over the regular dividend declared in the prior quarter. The Board of Directors has authorized the supplemental cash dividend in order to comply with regulated investment company tax requirements for distributing its undistributed taxable income from FY23. The dates for the regular and new supplemental dividend are a record date of September 30 and a payment date of October 13.

16:06 EDT Standard Lithium acquires 118 acres of land for South West Arkansas Project - Standard Lithium acquired 118 acres of land intended to advance development of its South West Arkansas Project. The 118-acre parcel is located in Lafayette County, Arkansas near state highway 29 which historically has been used to access logging operations. A portion of the property has previously been logged and the remainder of the harvestable timber will be removed before the end of the year by the previous owner. The SWA Project's Indicated and Inferred Mineral Resource of 1.4 Mt and 0.4 Mt lithium carbonate equivalent, respectively, has some of the highest reported lithium brine concentrations in North America, averaging above 400 mg/L. The recent Preliminary Feasibility Study assumes production of at least 30,000 tons per year of battery-quality lithium hydroxide beginning in 2027. Currently, the Project contemplates 91 full-time equivalent employees upon reaching commercial production. The company anticipates completing a FEED and Definitive Feasibility Study for the SWA Project in 2024 and beginning construction in 2025. The SWA Project is expected to reach commercial production in 2027, subject to continuing project definition, due diligence, project financing and receipt of future feasibility studies.

16:04 EDT Ball Aerospace, NASA complete primary instrument for Roman Space Telescope - Ball Aerospace and its partners at NASA's Goddard Space Flight Center have successfully completed assembly of the Nancy Grace Roman Space Telescope's camera system, called the Wide Field Instrument. The WFI will serve as the observatory's primary instrument, providing the scientific community with detailed and expansive images of the cosmos. The Roman Space Telescope is expected to launch no later than May 2027.

15:53 EDT WW says Sequence being impacted by GLP-1 supply constraints - Asked during the Morgan Stanley Global Healthcare Conference about how supply constraints across GLP-1s have impacted Sequence, executives from WW said: "So I'll talk about the supply constraints. And obviously, they are impacting us in the space in general. There are supply constraints going on in the space. And, what I would share is all the good work we're doing to ready for when supply returns or starts to grow back to a normal or consistent growth rate. So, during this time, we are leaned into working on our integration, so integrating Weight Watchers and Sequence into a common platform, integrating the experience into our app. Getting ready our GLP-1 Companion Program to launch ahead of peak season. And by that, I mean, members can come into Weight Watchers and sign up for our core program, and it is a healthy habit building behavior change a based program. You can identify on the way into that program as I'm diabetic. And we're going to give you a tailored diabetic program, et cetera. We work to tailor to your needs. And we will be tailoring and launching program tailored to the needs of people on a GLP-1 program and launching that ahead of our peak season, and that will be complementary to a sequent subscriber, but also available to our general membership because there will be people who come through that would like the GLP-1 behavior change support, but maybe they have access elsewhere or maybe they don't have an insurance need or some of the needs that are built into what we're providing the team has spoke to, within Sequence. So we're leaned into integration. We're also leaned into testing and learning during this time frame. We've not really unleashed marketing yet. Sima can speak to the marketing efforts, but we're readying and testing and thinking about what to do from a marketing perspective when the time comes that we're comfortable that supply is returning."

15:00 EDT FDA identifies Abbott Proclaim recall as Class I - Abbott is recalling its Proclaim and Infinity IPGs due to complaints from patients who are unable to exit MRI mode, noted the FDA, which identifies July 18 as the date the recall was initiated by the firm. "The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death," the recall notice posted today to the FDA site stated. Reference Link

14:10 EDT Alphabet announces new apps for Android Auto, including WebEx by Cisco and Zoom - Haris Ramic, Director, Product Management Android Auto, Android, announced in a blog post: "Beginning today, WebEx by Cisco and Zoom are both rolling out on Android Auto with audio-only capability, introducing a whole new category of apps. Years ago, the ability to answer a phone call directly from your car display revolutionized how we communicate on the road. We're taking the next step by making it easy and safe for you to quickly join scheduled meetings and conference calls from your car display, so you won't have to go fumbling for your phone... [Amazon (AMZN)] Prime Video is now available on Google Play for select Renault, Polestar and Volvo Cars, with other brands to follow. Whether you're waiting for school to let out or charging your vehicle, you can now catch up on your favorite content... We're also expanding your parked entertainment options beyond video. Already available in some cars as a standalone app, Vivaldi, a Chromium-based internet browser, is rolling out starting today on Google Play in the car." Reference Link

13:57 EDT North American rail traffic down 3% for the week ending September 9 - The Association of American Railroads or AAR reported U.S. rail traffic for the week ending September 9. For this week, total U.S. weekly rail traffic was 447,345 carloads and intermodal units, down 1.7% compared with the same week last year. Total carloads for the week ending September 9 were 218,101 carloads, up 0.6% compared with the same week in 2022, while U.S. weekly intermodal volume was 229,244 containers and trailers, down 3.8% compared to 2022. Six of the 10 carload commodity groups posted an increase compared with the same week in 2022. They included motor vehicles and parts, up 1,585 carloads, to 14,913; petroleum and petroleum products, up 1,416 carloads, to 9,734; and coal, up 866 carloads, to 68,367. Commodity groups that posted decreases compared with the same week in 2022 included grain, down 2,427 carloads, to 14,626; nonmetallic minerals, down 679 carloads, to 30,163; and forest products, down 514 carloads, to 7,840. North American rail volume for the week ending September 9 on 12 reporting U.S., Canadian and Mexican railroads totaled 323,563 carloads, up 0.0% compared with the same week last year, and 305,358 intermodal units, down 6% compared with last year. Total combined weekly rail traffic in North America was 628,921 carloads and intermodal units, down 3%. North American rail volume for the first 36 weeks of 2023 was 23,304,320 carloads and intermodal units, down 4.1% compared with 2022. Publicly traded companies in the space include CSX (CSX), Canadian National (CNI), Canadian Pacific Kansas City (CP), Kansas City Southern (KSU), Norfolk Southern (NSC), Union Pacific (UNP), Greenbrier (GBX), Trinity Industries (TRN), Wabtec (WAB), Rail Vision, (RVSN) and FreightCar America (RAIL). Reference Link

13:16 EDT Lear down 5% as conference presentation continues - Shares of Lear are down $7.19, or 5%, to $136.05 as executives from the company present at the Morgan Stanley Laguna Conference.

12:24 EDT Adobe releases new Firefly generative AI models, web app - Adobe earlier announced the launch of the new Firefly web application, a playground for exploring AI-assisted creative expression. After a six-month beta, Firefly-powered capabilities are now deeply integrated into creative workflows across Adobe Creative Cloud, Adobe Express and Adobe Experience Cloud and available for commercial use, Adobe said in a statement. "With over two billion generations, creators amazed us with their engagement and feedback to the Firefly beta, inspiring us to deliver generative AI capabilities that are designed to be commercially safe and seamlessly integrated into the interfaces customers love," said Ely Greenfield, chief technology officer, Digital Media at Adobe.

12:00 EDT SilverBow Resources falls -9.9% - SilverBow Resources is down -9.9%, or -$4.17 to $37.99.

12:00 EDT Sunlands Online falls -13.6% - Sunlands Online is down -13.6%, or -95c to $6.06.

12:00 EDT AMC Entertainment rises 7.0% - AMC Entertainment is up 7.0%, or 53c to $8.10.

11:59 EDT Netflix 'in games for the long-term,' says CFO

11:56 EDT Netflix 'has been managing' in 18%-20% operating margin range, says CFO

11:27 EDT Sidus Space granted additional 180 days to regain compliance with Nasdaq - Sidus Space announced that it has been granted an additional 180 calendar days, or until March 11, 2024, to regain compliance with Nasdaq.

11:22 EDT Moderna sees combo flu/COVID vaccine available as early as 2025 - Shares of Moderna are up $6.65, or 6%, to $111.89 after the company earlier announced business and clinical updates across its franchises and introduced several new development programs at the company's annual R&D Day. Moderna stated: "On September 11, 2023, the U.S. Food and Drug Administration approved the supplemental Biologics License Application for Spikevax for ages 12 years and above. Emergency Use Authorization for the Moderna COVID-19 Vaccine was also received for individuals 6 months through 11 years of age. Moderna's updated COVID-19 vaccine contains spike proteins for the XBB.1.5 sublineage of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older. Clinical trial data confirm mRNA-1273.815 showed a strong immune response in humans against BA.2.86, EG.5 and FL.1.5.1 variants. With the U.S. FDA's decision, Moderna has begun shipping doses to vaccination sites across the U.S., with updated vaccines expected to be available in the coming days. In addition, the company's next-generation, refrigerator-stable COVID-19 vaccine, mRNA-1283, demonstrated encouraging results in multiple clinical studies and has now completed enrollment of its Phase 3 trial... Moderna's development strategy for combination vaccines can provide substantial public health benefits. The company's combination vaccine candidates address respiratory viruses associated with the largest disease burden in the category and are designed for higher compliance, increased uptake, consumer convenience and benefits to healthcare systems. Enrollment is now complete in the following combination trials: Flu/COVID-19 (mRNA-1073: mRNA-1010 + mRNA-1273) Phase 1/2; Flu/RSV (mRNA-1045: mRNA-1010 + mRNA-1345) Phase 1; Flu/COVID-19/ RSV (mRNA-1230: mRNA-1010 + mRNA-1273 +mRNA-1345) Phase 1; Flu/COVID-19 (mRNA-1083: mRNA-1010 + mRNA-1283) Phase 1/2. The company intends to have a combination vaccine available as early as 2025 and expects to regularly update combinations with improved next-generation vaccine candidates as appropriate. The Company further expects to provide an investor update in Q4 of this year."

11:20 EDT Moderna up after forecasting up to $15B in sales by 2027 from respiratory drugs - Shares of Moderna are up $6.65, or 6%, to $111.89 after the company earlier announced business and clinical updates across its franchises and introduced several new development programs at the company's annual R&D Day. "Our mRNA platform is working. With today's positive Phase 3 flu results, along with previous results in COVID and RSV, we are now three for three on advancing respiratory disease programs to positive Phase 3 data. In the near term, we look forward to product launches in our oncology, latent, rare and infectious disease franchises.In the fourth quarter of this year, we also expect to provide data on our next-generation COVID and flu combination, mRNA-1083, and additional efficacy analysis on our Phase 2 INT study. With significant momentum across the business and our pipeline, we are excited by the near future and focused on execution," said Stephane Bancel, CEO of Moderna. "The respiratory franchise, now a seasonal business with an annual recurring revenue stream, is targeting an approximately $30B annual market, comprised of an approximately $15B COVID-19 market, a $10B RSV market, and a $6B flu market, with the potential for growth with more effective vaccines. Respiratory products sales in 2027 are expected to be in the range of $8B to $15B, depending on vaccination rates, efficacy and company market share, as previously communicated at Vaccines Day," Moderna stated.

11:18 EDT National CineMedia, Religion of Sports enter new content partnership - National CineMedia and Religion of Sports, or ROS announced a new content partnership bringing stories of athletes and sports to the big screen for the first time. ROS was founded by filmmaker and producer Gotham Chopra, American football legend and Hall of Famer Michael Strahan, and seven-time Super Bowl champion Tom Brady. Each of Religion of Sports' sixty-second episodes will feature a human-interest story where sports had an impact on an individual, team or community. The six-part content series launches in September and will run as part of NCM's The Noovie Show, which airs in 19,000 + theaters nationwide before the film trailers and will be available for brand sponsors.

11:14 EDT Astra Space announces 1-for-15 reverse stock split - Astra Space announced that the company's board of directors has approved a reverse stock split of Astra's Class A common stock, par value $0.0001 per share, and Astra's Class B common stock, par value $0.0001 at a ratio of 1-for-15. The reverse stock split is expected to become effective immediately after the close of the trading day on the Nasdaq Capital Market on September 13 and the Class A Common Stock will begin trading on the Nasdaq on a reverse split-adjusted basis on September 14 under the ticker symbol (ASTR).

11:13 EDT Genius Sports enters partnership with Snap to power augmented reality - Genius Sports (GENI) has struck a new partnership with Snap (SNAP) to power augmented reality, or AR, fan experiences via Snapchat Lenses. Genius Sports will help to power the next wave of Snapchat Lenses through NFL Official League Data, providing millions of fans with phone-based, shareable content. Genius Sports is also the exclusive distributor of the NFL Official League Data and Next Gen Stats feeds to global media and betting markets. The sponsored Lens provides a powerful way for Verizon, the Official 5G Network of the NFL, to connect with fans through the power of AR. Verizon will be the first sponsor to run a Lens that incorporates Genius Sports technology. As part of this partnership, Genius Sports and Verizon's 5G network will help to power Verizon's NFL Lens, including live data visualizations and an AR commerce platform. The Lens will debut at SoFi Stadium on September 17 when the LA Rams host the San Francisco 49ers and will include real-time game stats, merch try-on, and a 3D interactive map of the stadium, exclusively for Verizon 5G customers.

11:11 EDT Citi still sees 11%-12% RoTCE in medium-term

11:10 EDT Citi sees modest level of buybacks in Q3

11:10 EDT Citi sees trading revenue up low single digits y/y

11:06 EDT IntercontinentalExchange announces IBA collaboration with Meridia Land B.V. - Intercontinental Exchange announced that ICE Benchmark Administration, or IBA, is collaborating with Meridia Land B.V, an agricultural technology company specializing in the verification of farm origin and supply chain data, to launch the ICE Commodity Traceability service. ICE CoT is a technology platform designed to maintain the frictionless trade of physical cocoa and coffee by supporting these industries' compliance with the European Union's Deforestation Regulation. Europe is the largest market for cocoa and coffee worldwide. ICE CoT aims to automate the process of submitting, storing, and validating the information necessary for cocoa and coffee operators and traders to ensure and demonstrate compliance of their products with the regulation. ICE CoT is aimed at supporting all commercial trade affected by the EUDR.

11:05 EDT Grubhub brings mobile ordering, pickup to Naval Station Norfolk - Grubhub is bringing its Grubhub Onsite mobile ordering and pickup technology to Naval Station Norfolk through a business venture with The Navy Exchange Service Command, or NEXCOM. Rob DelaCruz, vice president and general manager of Onsite at Grubhub, said "Grubhub's Onsite platform technology was built to support an array of ordering environments, and we're honored to bring this ordering capability to the Naval Station Norfolk."

11:03 EDT Sleep Number shareholder issues letter to board regarding execution - Stadium Capital sent the below letter to Sleep Number's board of directors: "Stadium Capital Management, LLC (collectively with its affiliates, "Stadium Capital" or "we") is the beneficial owner of approximately 9% of the outstanding common shares of Sleep Number Corporation ("Sleep Number" or the "Company"), making us a top five shareholder of the Company. We are not typically activist investors and strongly prefer to collaborate privately with those who lead our portfolio companies. Our investment in Sleep Number was made following several years of diligence into the Company, its customer base and store fleet, and relevant operating markets. Given our alignment with fellow shareholders and years of in-depth analysis, we believe Stadium Capital is ideally positioned to (i.) diagnose the issues adversely affected by the business, (ii.) provide value-enhancing ideas and (iii.) support the Board of Directors (the "Board") as it oversees management's strategic decisions, forecasting and operational execution. To be clear, we believe Sleep Number is a tremendous brand with a compelling, differentiated product set and an attractive business model. Unfortunately, these positive attributes have been obscured by poor execution and ineffective corporate governance from our view. We believe the Board has failed to oversee accretive capital allocation, effective forecasting and a culture of strong accountability for management. Meanwhile, Sleep Number executives and directors have received tens of millions of dollars in dilutive compensation over the past decade. All of this has resulted in Sleep Number producing unacceptable negative total shareholder returns ("TSR") over the past 10+ years. In our view, shareholder-driven change in the boardroom is necessary to address Sleep Number's abysmal TSR, suspect governance and questionable transformation strategy. As a starting point, we believe Sleep Number needs targeted changes to the composition of its Board to ensure the Company's positive attributes translate into enhanced future shareholder returns. The Board, as presently constituted, includes long-tenured members who have been part of questionable decisions and would likely not fare well in a contested election next year. Given the urgent problems at Sleep Number, we are disappointed in the Board's tone-deaf response to our proposal to add one Stadium Capital representative to the Board and appoint two additional independent directors. Instead, by suggesting we align on a "mutual director," you offered that the same entrenched group runs the same process used in past years to pick a single new director, who would specifically not be a shareholder. In return for minimal participation in this process, we were nevertheless asked to give up our voice and our valuable voting rights by agreeing to a "customary standstill." Prior Board-led "refreshes" have clearly not produced acceptable returns; as such, we have no reason to expect that this time will be any different. Furthermore, the Board's characterization that a Stadium Capital representative would only represent Stadium Capital's interests, not the interests of all shareholders, is preposterous coming from a Board that has: Failed to follow basic corporate governance best practices, such as maintaining a de-classified Board or separating the roles of Chairman and CEO; Enriched itself at the expense of shareholders by taking dilutive compensation during a period of massive value destruction; Members who have been net sellers of Sleep Number stock and collectively own a fraction of the stock that Stadium Capital owns, and; Determined that spending investor resources on defense advisors is preferred to adding a shareholder representative and independent directors to the Board... We are strong believers in the Sleep Number brand, but we also believe that the Company is materially undervalued and underperforming relative to its potential. We have grave concerns that deficiencies in the boardroom are an impediment to realizing the true value of Sleep Number's brand and business model. Rather than debate the facts and work at cross purposes, we urge you to collaborate with us on a Board refresh that includes a Stadium Capital representative and other new directors with relevant expertise. As a next step, we request that the independent members of the Board meet with us this month. We wish to share our perspectives and demonstrate the depth of work we have conducted on the business. We are confident that if you meaningfully engage with us, you will realize that we can add substantial value for all Sleep Number shareholders. Thoughtful and genuinely collaborative Board changes can help Sleep Number begin to regain some semblance of shareholder trust, even as it maintains an outdated classified Board structure and other unfriendly governance policies."

10:59 EDT TKO Group declares $3.86 per share special cash dividend - TKO Group announced that it has declared a special cash dividend pursuant to the terms of the transaction agreement between UFC and WWE, which provides for a special one-time dividend on TKO's shares of Class A common stock, funded by an intracompany cash distribution to TKO prior to the consummation of the transaction. The dividend to TKO's Class A common stockholders will be $3.86 per share, payable on September 29 to TKO's Class A common stockholders of record as of September 22.

10:58 EDT Electriq Power announces new program with California city - Electriq Power announced a new program with the City of Carpinteria, California, to provide affordable and sustainable solar and storage solutions to residents with zero up-front costs, no matter their socioeconomic status. Through the program's City-vetted Power Purchase Agreement, or PPA, called the PoweredUP Network, all Carpinteria homeowners, regardless of means, will have access to a turnkey, distributed home energy solution, including smart battery storage.

10:57 EDT Papa John's chief international, development officer to become international COO - Papa John's announced updates to its executive leadership team. Amanda Clark will transition from her role as chief international and development officer to become COO, international, focusing on the operations and development of the Papa Johns footprint in international markets. Chief restaurant officer Joe Sieve will assume North American development responsibilities. He will also continue to oversee corporate and franchise restaurant operations in North America. The new appointments are effective as of September 18.

10:55 EDT Takeda announces FDA acceptance for review of its Entyvio BLA - Takeda announced that the FDA has accepted for review its biologics license application, or BLA, for the investigational subcutaneous, or SC, administration of Entyvio for maintenance therapy in adults with moderately to severely active Crohn's disease, or CD, after induction therapy with Entyvio intravenous, or IV. An application for the SC administration of Entyvio for the treatment of adults with moderately to severely active ulcerative colitis, or UC, is also under review by the FDA.

10:54 EDT Honeywell technologies to support new American Battery Factory gigafactory - Honeywell announced that American Battery Factory, a Lithium Iron Phosphate battery cell manufacturer, is fully integrating Honeywell's automation and process safety solutions in its new gigafactory located in Tucson, Ariz. At approximately 2M square feet, the facility will be the largest gigafactory to produce LFP battery cells in the United States upon completion. Energy storage systems made from ABF's battery cell production will be available to households, businesses and utilities, allowing them to optimize their use of energy from the grid or from their own systems. The Arizona gigafactory will integrate Honeywell's Manufacturing Excellence Platform, Experion Batch, and Integrated Remote operations to help ABF optimize its manufacturing process and workflow. Honeywell's innovative solutions will allow ABF to visualize and control their battery production process in real-time -- from mixing, coating and assembly to storage and distribution. Honeywell's technologies will also streamline and improve the collection of operations data while gathering insights about upcoming tasks or potential delays for operators. The results: improved yields, reduced waste and the achievement of more energy-efficient and cost-effective battery production.

10:52 EDT Chipotle brings Carne Asada back to menu for limited time - Chipotle Mexican Grill announced it is bringing back Carne Asada in the U.S. and Canada for a limited time. The popular protein has been revered by Chipotle fans for years, and this marks the third time it is making a comeback to Chipotle's menu.

10:50 EDT CVS Health says updated COVID-19 vaccines now available - CVS Health announced that the updated COVID-19 vaccine recently authorized by the FDA and recommended by the CDC is now available at its CVS Pharmacy locations. Pharmacies will begin receiving the new vaccine today and will continue to receive inventory on a rolling basis throughout the week. All CVS Pharmacy locations are expected to have the vaccination in stock by early next week. Appointments for individuals aged five and above are made available at CVS.com and via the CVS Pharmacy app, and walk-ins will be accepted as individual locations receive the vaccines. MinuteClinic locations will also begin offering the new COVID-19 vaccine for patients aged 18 months and above in the coming weeks, with appointments available at MinuteClinic.com.

10:48 EDT Byrna partners with Sean Hannity to amplify non-lethal security solutions - Byrna Technologies announced its strategic partnership with Sean Hannity, a dedicated advocate for non-lethal security. As a loyal customer and supporter of Byrna, Hannity will extend his advocacy by featuring the Company on his influential radio show and various Hannity platforms in the coming months.

10:45 EDT Q32, Horizon announce dosing of first patient in Phase 2 Bempikibart trial - Q32 Bio and Horizon Therapeutics (HZNP) announced that the first patient has been dosed in a randomized, double-blind, placebo-controlled, Phase 2 multicenter, proof-of-concept study to evaluate bempikibart in adult patients with severe alopecia areata. Q32 Bio and Horizon are collaborating to develop bempikibart, a fully human anti-IL-7Ralpha antibody that re-regulates adaptive immune function by blocking signaling mediated by both IL-7 and TSLP, two key immune pathways. "Dosing of the first patient in the Phase 2 study in alopecia areata, in addition to our ongoing Phase 2 study in atopic dermatitis, demonstrate the breadth of potential applications of bempikibart and our deep commitment to transform the lives of patients with autoimmune and inflammatory diseases," said Jodie Morrison, acting CEO, Q32 Bio. "Q32 Bio and Horizon are mutually dedicated to advancing bempikibart expeditiously through both Phase 2 studies."

10:42 EDT Bank of America expands fee waivers for SafeBalance accounts - Bank of America announced plans to expand the monthly maintenance fee waiver criteria for SafeBalance, an easy-to-use account that helps clients manage day-to-day finances with no overdraft fees. Beginning in November 2023, accounts that maintain a minimum daily balance of $500 or more will have the $4.95 monthly fee waived. In addition, the fee will be waived on accounts with an owner under the age of 25, regardless of daily balance. Previously, clients had to be enrolled in school to qualify for the fee waiver. Preferred Rewards clients will also continue to have their monthly fee waived.

10:40 EDT Novo Nordisk conducts two-for-one stock split - Novo Nordisk stated: "As communicated on 10 August 2023 in connection with the release of Novo Nordisk's financial results for the first six months of 2023, Novo Nordisk's Board of Directors has approved a split of the trading units of the Novo Nordisk B shares listed on Nasdaq Copenhagen and of the American Depositary Receipts (ADRs) listed on New York Stock Exchange in a two-for-one ratio. Novo Nordisk's B shares have been listed on Nasdaq Copenhagen in trading units of DKK 0.20 and its American Depositary Receipts that equal B-shares of DKK 0.20 have been listed on New York Stock Exchange. Consequently, the trading unit of the Novo Nordisk B shares listed on Nasdaq Copenhagen has been changed from DKK 0.20 to DKK 0.10 as of 13 September 2023. The ADRs will similarly be split as of 20 September 2023 to maintain the one-to-one relationship between the B-share and the ADR."

10:38 EDT Ares Acquisition, X-Energy Reactor announce updates to business combination - X-Energy Reactor and Ares Acquisition Corporation (AAC) announced strategic updates to their previously announced business combination. Ares Management (ARES) has committed to a PIPE investment comprising $50M of convertible preferred stock, or PIPE, in the combined company, and X-energy founder and executive chairman, Kam Ghaffarian, has agreed to contribute approximately $30M to repay certain of X-energy's outstanding debt and will receive an additional approximately $30M of PIPE shares upon the closing of the transaction. The PIPE investment and contribution are anticipated to close in connection with the completion of the business combination. When combined with Ares' existing $30M investment funded shortly after the transaction announcement in December 2022, Ares will have invested a total of $80M in X-energy upon the closing of the business combination. Combined with X-energy's $103M C-2 private financing and cash-in-trust, this additional capital is expected to deliver approximately $534M to the combined company, assuming no redemptions by AAC shareholders in connection with the shareholder vote to approve the business combination. The additional capital will help accelerate the development and deployment of X-energy's advanced technology. In connection with the Investments, X-energy and AAC have amended the terms of their business combination agreement to revise X-energy's pre-money equity value to $1.05B from $1.8B.

10:35 EDT Icon partners with BARDA on next generation COVID-19 vaccine candidate trial - Icon announced that it is partnering with the U.S. Biomedical Advanced Research and Development Authority, or BARDA, part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, to execute a clinical trial to evaluate the effectiveness of next generation COVID-19 vaccine candidates. Next generation COVID-19 vaccines could have the potential to expand the breadth of coverage against existing and future variants of the virus, extend the duration of protection, and offer better protection in the prevention of illness and transmission over the current state of vaccine technologies. Against this backdrop, the Government & Public Health Solutions team at Icon will execute a Phase 2b clinical trial to assess the relative efficacy of a next generation COVID-19 vaccine compared to currently approved/authorized COVID-19 vaccines in the prevention of symptomatic, PCR confirmed SARS-CoV-2 infection. The trial will involve 10,000 subjects, expected to be enrolled over a six-month period. BARDA will select the vaccine candidate to be investigated in this trial, thereby accelerating the start of the Phase 2b clinical trial to support in benchmarking its efficacy against existing vaccines.

10:33 EDT Hertz announces departure of COO Paul Stone - Hertz Global Holdings announced that Paul Stone, COO and president, will step down from his role effective September 30, to pursue opportunities in the retail sector, where he began his career. Paul will remain employed with the company in a transitional capacity through October 31. The company will conclude a search for a COO in short order. In the interim, key operations leadership will report directly to Stephen Scherr, chair and CEO.

10:33 EDT Citi to eliminate certain management layers - Citi earlier announced significant changes to its organizational model that will fully align its management structure with its business strategy and simplify the bank. The new, flatter structure elevates the leaders of Citi's five businesses and eliminates management layers, which will speed up decision making, drive increased accountability and strengthen the focus on clients. Simplifying the organization will also advance the execution of Citi's Transformation, the firm's top priority. "I am determined that our bank will deliver to our full potential, and we're making bold decisions to meet our commitments to all our stakeholders," said Citi CEO Jane Fraser. "These changes eliminate unnecessary complexity across the bank, increase accountability for delivering excellent client service and strengthen our ability to benefit from the natural linkages that exist amongst our businesses, all with an eye toward delivering on our medium-term targets and our Transformation." The leaders of each of Citi's five interconnected businesses will now report directly to the CEO and be members of the Executive Management Team. This will allow them to have greater influence on Citi's strategy and execution, while enhancing accountability. Citi said: "The new model will simplify the bank in a number of ways, including eliminating the Personal Banking & Wealth Management and Institutional Clients Group management layers, as well as the existing regional layers in Asia Pacific, Europe, Middle East and Africa, and Latin America. As Citi swiftly transitions to this new model, the firm is committed to retaining top talent and supporting employees who are leaving the company."

10:32 EDT Jayud Global Logistics extends logistics services agreement with Lenovo - Jayud Global Logistics Limited announced a significant extension of its Logistics Service Agreement with Lenovo PC HK Limited, further enhancing its provision of post-sale logistics services. The Lenovo Agreement was renewed based on the initial agreement executed in November 2017. Under the terms of the Lenovo Agreement, Jayud will continue to provide its foundational logistics services to Lenovo while broadening its scope to include robust post-sales support and services. This enhancement is designed to strengthen Lenovo's commitment to its global clientele and maintain its position at the forefront of the technology industry.

10:27 EDT Palantir signs partnership with Babcock International Group - Palantir Technologies is enabling the Babcock International Group to strengthen its digital defense capabilities through an Enterprise Agreement announced at DSEI in London. The partnership will leverage Palantir AIP, the AI-enabled instance of the company's software, that will aim to transform how the Babcock workforce captures, integrates, models and builds data-driven solutions. Unlocking the power of data in this way will enable Babcock to make better informed, data-driven decisions, maximize platform availability on customer assets, and understand how to derive even more value from the organization's data.

10:25 EDT Ecovyst to expand silica catalyst production capability at Kansas City facility - Ecovyst announced plans to expand silica catalyst production capability at its manufacturing facility in Kansas City, The company expects that growing consumer demand for plastics will continue to drive the global expansion of polyethylene production over the coming years. Silica supported catalysts play a crucial role in the production of high-density polyethylene, or HDPE, and linear-low density polyethylene, or LLDPE. The Kansas City expansion is expected to increase the site's silica catalyst production capability by approximately 50% and is anticipated to start late 2025.

10:24 EDT Sunrise New Energy applied two more patent in hard carbon composite materials - Sunrise New Energy announced that Sunrise New Energy Materials has applied two more patents of in hard carbon composite materials in September, including 202311166138.4-2023091101651000: A Preparation Method for Metal Sulfide Doped Hard Carbon Composite Materials and 2023111652084 -2023091101479840: A hard carbon composite material doped with antimony alloy and its preparation method. In addition, the Company also granted two new invention patents in August, namely 202211427206.3-2023082400873250: A Preparation Method for Anode Materials Used in Long Cycle Lithium Ion Batteries and 202211427111.1 -2023081800130520: A Preparation Method for High Energy Density Fast Charging Anode Materials. As of today, the Company's patent portfolio has reached a total of 50 applied, domestic and international, of which 25 have been granted.

10:23 EDT Alnylam reports FDA committee meeting to review sNDA for patisiran - Alnylam announced that Nasdaq has halted trading of the company's common stock. The U.S. FDA Cardiovascular and Renal Drugs Advisory Committee is meeting to review the supplemental new drug application, or SNDA, for patisiran, an investigational RNAi therapeutic in development for the treatment of the cardiomyopathy of transthyretin-mediated, or ATTR, amyloidosis. The advisory committee meeting is scheduled to begin at 9:00 a.m. ET today. As previously announced, the FDA has set an action date of October 8 under the Prescription Drug User Fee Act.

10:23 EDT Avalon's Laboratory Services MSO acquires Merlin Medical Supply - Avalon GloboCare announced Laboratory Services MSO has acquired Merlin Medical Supply. Additionally, LSM has acquired Leading Edge Innovations from the same owner. Leading Edge Innovations owns the GeeWhiz External Condom Catheter, a patented, FDA-registered, in-market, male incontinence device. Avalon owns a 40% interest in LSM. "MMS has been servicing the community in Ventura for over 20 years and is an in-network provider for major insurance companies, including Medicare and Medicaid," commented David Jin, M.D., Ph.D., President and Chief Executive Officer of Avalon. "By combining MMS with LSM, we look forward to supporting their national expansion. Notably, LSM also acquired a proprietary, FDA-registered, external male catheter device - GeeWhiz. The GeeWhiz External Condom Catheter is approved for reimbursement by Medicare and a number of high-profile private insurance providers. The GeeWhiz catheter device system is designed to help men with urinary incontinence and bladder control. We expect LSM to greatly benefit from acquiring these turn-key and accretive businesses, which provide the opportunity to not only grow sales, but also improve profit margins by integrating them into LSM's existing operations."

10:20 EDT Magic Empire Global announces $2M share repurchase plan - Magic Empire Global announced that its board of directors has authorized a share repurchase plan under which the Company may repurchase up to US$2M of its shares over the next 12 months. The Company expects to fund repurchases made under this plan from its existing funds. MEGL's board of directors will review the share repurchase plan periodically, and may authorize adjustment of its terms and size.

10:20 EDT Evolution Petroleum, PEDEVCO enter strategic partnership - Evolution Petroleum Corporation (EPM) and PEDEVCO Corp. (PED) announced entry into a definitive participation agreement to jointly develop PEDEVCO's Chaveroo oilfield in the Northwest Shelf of southeastern New Mexico, a conventional oil-bearing San Andres field in the Permian Basin located in Chaves and Roosevelt Counties. The Chaveroo field was originally developed with vertical wells on 40-acre spacing. PEDEVCO has drilled ten horizontal infill wells on ~20-acre spacing which yields most of the field's current production. The agreement covers approximately 16,000 acres with average working interest and net revenue interest of 100% and 82%, respectively, all currently owned by PEDEVCO. Evolution will farm-in for an average 50% WI in future horizontal drilling locations on a block-by-block basis with PEDEVCO remaining the operator.

10:19 EDT Scilex to buy all common, preferred, warrants held by Sorrento - Scilex Holding (SCLX), a majority-owned subsidiary of Sorrento Therapeutics, announced that on September 11, 2023, Scilex, Oramed Pharmaceuticals (ORMP) and Sorrento executed non-binding term sheets relating to, among other things, the Securities Transfer and the Note. The transactions contemplated by the Scilex Term Sheets are expected to close on or about September 19, 2023. Pursuant to the Securities Transfer Term Sheet, the parties to the Securities Transfer Term Sheet agreed that the Company would be declared the new successful bidder and would acquire all of the shares of Scilex common stock owned by Sorrento, all of the shares of Scilex preferred stock owned by Sorrento, and all of the warrants for the purchase of shares of Scilex common stock owned by Sorrento for aggregate consideration consisting of: $110 million; plus the assumption by the Company of certain legal fees and expenses in the amount of approximately $12.25 million; plus a credit bid of all amounts owed to the Company under the junior secured term loan facility provided by the Company to Sorrento. "This transaction is a testament to our significant execution over the past few years as well as our board's confidence in our multi-faceted strategy to continue to build long term value for our shareholders. Approximately four years ago, we successfully merged Semnur Pharmaceuticals and Scilex Pharmaceuticals into Scilex Holding Company. On November 10, 2022, we completed our business combination to become a public company and began trading on Nasdaq on November 11, 2022. Our achievements over these past years demonstrates the ability of our management team to execute on its goals. This transaction reinforces the confidence we have in our strategy and our commitment to deliver long-term value to our shareholders," said Jaisim Shah, President and Chief Executive Officer of Scilex.

10:18 EDT Penns Woods Bancorp announces 'at-the-market' equity offering program - Penns Woods Bancorp announced that it has filed with the Securities and Exchange Commission a prospectus supplement to its existing shelf registration statement on Form S-3, under which it may offer and sell shares of its common stock having an aggregate offering price of up to $20 million from time to time through an "at-the-market" equity offering program. The timing and amount of any sales will be determined by a variety of factors considered by the Company.

10:18 EDT Restaurant Brands receives TSX approval for NCIB - Restaurant Brands announced that it has received approval from the Toronto Stock Exchange, or TSX, for its previously announced renewal of its normal course issuer bid for its common shares. The NCIB is being conducted in furtherance of RBI's board-approved share repurchase authorization announced on August 31 that allows RBI to purchase up to $1B of its common shares over the next two years through September 30, 2025.

10:18 EDT TOMI announces partnership with Avantor to expand presence of SteraMist - TOMI Environmental Solutions (TOMZ) announced expansion of their distribution channels with Avantor (AVTR). This agreement represents a significant milestone for TOMI and highlights a shared commitment to advancing public health and safety. Elissa J. Shane, COO of TOMI Environment Solutions, expressed her enthusiasm about the partnership, stating, "Joining forces with Avantor strengthens our commitment to promoting the well-being of businesses and communities safeguarding all critical environments. Avantor's professionalism, reputation, and reach align perfectly with our mission and this collaboration will play a pivotal role in expanding the use of our SteraMist Surface Unit, SteraMist Environment System, and iHP Custom Engineered System in cleanrooms or controlled environments achieving unparalleled cleanliness and disinfection decontamination levels."

10:18 EDT Presidio establishes special committee to explore strategic alternatives - Presidio Property Trust announced that its Board of Directors has established a Special Committee of the Board to explore potential strategic alternatives focusing on maximizing stockholder value. The Special Committee is comprised solely of independent directors and is charged with exploring potential strategic alternatives, including, without limitation, a business combination involving the Company, a sale of all or part of the Company's assets, joint venture arrangements and/or restructurings, and determining whether a strategic transaction is in the best interests of the Company. There can be no assurance that the strategic alternatives exploration process will result in any transaction being pursued or consummated.

10:17 EDT Quisitive Technology completes 365 migration for manufacturing industry leader - Quisitive Technology Solutions announced that it has successfully completed the migration of a global manufacturer of diversified products, from Microsoft Dynamics AX to Dynamics 365 Finance & Supply Chain Management. As part of the global digital transformation strategy, the customer needed a partner to lead their migration from an on-premise legacy system to a modern, cloud-based solution. The initiative lasted 12 months and represented 1,000 Microsoft Dynamics 365 F&O licenses consolidating 700 legal entities and over 200 manufacturing plants. The project also included over 70 integrations to the customer's existing platforms to ensure a streamlined business process and holistic view of the business.

10:17 EDT Quarterhill announces C$13.7M HDOT contract for IRD - International Road Dynamics, a wholly-owned subsidiary of Quarterhill, announced today that it has been awarded a contract by the State of Hawaii Department of Transportation, or HDOT, for Continuous Traffic Monitoring, or CTM, Data Collection Goods and Services Statewide. CTM systems collect traffic volume, speed, vehicle classification, and weight data to support HDOT's continuous traffic monitoring program. The total five-year contract value is C$13.7M.

10:16 EDT DallasNews announces limited voluntary staff reduction program - DallasNews is announcing a limited voluntary staff reduction program that will be offered across all departments to eligible individuals at The News and Medium Giant. Though the exact number of people who will take the option is unknown, it is expected that this could ultimately reduce the total workforce by about 6 percent, or 40 full-time and part-time positions. "Like any business, DallasNews Corporation must achieve profitability to be a healthy and sustainable organization," said Grant Moise, the Company's Chief Executive Officer and publisher of The News. "While we will be parting with some who have been with us for many years, I hope this program will provide a helpful bridge to their next chapter. We are genuinely appreciative of their fine work."

10:15 EDT DevvStream to list on Nasdaq via combination with Focus Impact Acquisition - DevvStream Holdings (DEVS) and Focus Impact Acquisition Corp. (FIAC) announced that they have entered into a definitive Business Combination Agreement for a business combination. Focus Impact is a special purpose acquisition corporation focused on amplifying social impact through the pursuit of a merger or business combination with socially forward companies. The transaction is structured as an amalgamation of DevvStream into a wholly owned subsidiary of Focus Impact, following Focus Impact's redomiciling as an Alberta company. Focus Impact will be renamed DevvStream Corp. and continue the business of DevvStream following the amalgamation. It is a condition of the transaction that the securities of the combined company will be listed on the Nasdaq Stock Exchange, and the shares are expected to trade under the ticker symbol "DEVS".

10:14 EDT Inception Growth Acquisition, AgileAglo announce combination agreement - Inception Growth Acquisition (IGTA) and AgileAlgo Holdings Limited, a British Virgin Islands business company that, through its Singapore-based subsidiary, AgileAlgo Pte, announced they have entered into a definitive agreement for a business combination. Upon closing of the business combination), the combined company will be organized in the British Virgin Islands and renamed "Prodigy, Inc." and expects to list its ordinary shares on Nasdaq under the ticker symbol "PRGY." Under the terms of the Business Combination Agreement, (a) IGTA will be merged with and into its newly formed subsidiary IGTA Merger Sub Limited, a British Virgin Islands business company, with PubCo surviving the Redomestication Merger as a British Virgin Islands business company, and (b) immediately thereafter, PubCo shall acquire the outstanding shares of AgileAlgo from AgileAlgo's shareholders that are either parties to the Business Combination Agreement upon its initial signing. The total consideration to be paid by PubCo to the Sellers at the Closing will be based on a pre-money equity value of $160 million for 100% of AgileAlgo's outstanding shares, payable solely in new ordinary shares of PubCo, each valued at $10.00 per share. The boards of directors of IGTA and AgileAlgo both unanimously approved the proposed business combination. It is currently anticipated that the transaction will close in the first quarter of 2024, but in no event later than June 13, 2024

10:13 EDT Laboratorio Curie expands relationship with SOPHiA GENETICS - SOPHiA GENETICS has expanded its relationship with Laboratorio Curie, a leading laboratory located in the capital city of Paraguay. Laboratorio Curie is now live on the SOPHiA DDM Platform and will use the technology to deploy a new test that will identify BRCA gene mutations. Discoveries made using this test aim to enable Laboratorio Curie to support the increased use of precision medicine for hereditary cancers within the country.

10:11 EDT Takeda commits over $30M in five new global CSR partnerships - Takeda announced five new partnerships to its Global Corporate Social Responsibility, CSR, Program, which contribute to strengthening health systems in low- and middle-income countries. The new partnerships bring its total contributions to JPY 24.2 billion across 29 long-term partnerships. Takeda's commitments to these new partners in FY2023 include: JPY 834 million to Society for Family Health, Rwanda to expand access to quality healthcare in remote and hard-to-reach communities in Rwanda. JPY 1,146 million to Relief International to improve access to essential medicines and medical supplies in communities devastated by conflict, climate change and disaster in Afghanistan, Yemen, Myanmar and Syria. JPY 1,048 million to Mercy Corps to help climate-fragile communities save lives, improve health, and build climate resiliency for over 3 million people. JPY 671 millionto Partners In Health to elevate and equip 3,000 nurses and midwives in Haiti, Mexico, Peru, Lesotho, Liberia, Malawi, Rwanda and Sierra Leone. JPY 793 million to University of Nairobi to create a pioneering, public health-focused machine learning and data science training program to strengthen the leadership pipeline and impact of women to improve health in their communities.

10:07 EDT Aemetis signs permit for 90M gallon per year SAF, renewable diesel plant - Aemetis received a Use Permit from the City of Riverbank to build a 90M gallon per year sustainable aviation fuel, SAF, and renewable diesel plant at the 125-acre Riverbank Industrial Complex in Riverbank, California. The Riverbank Industrial Complex, a former U.S. Army ammunition production plant, is now being converted to business and industrial use as part of the federal Base Realignment and Closure program. "Aemetis continues to complete major milestones in our Five-Year Plan," said Eric McAfee, Chairman and CEO of Aemetis. "This Use Permit and CEQA approval for the Riverbank sustainable aviation fuel and renewable diesel plant is the result of years of engineering and environmental work with the City and several government agencies, allowing us to finalize additional key permits in the next few months."

10:07 EDT Aspira Women's Health regains Nasdaq compliance - Aspira Women's Health announced that it received written notice from the Nasdaq Stock Market on September 12, 2023 informing the Company that it has regained compliance with the market value of listed securities requirement, as set forth in Nasdaq Listing Rule 5550(b)(2) for continued listing on the Nasdaq Capital Market.

10:07 EDT BrainBox AI enters strategic collaboration with Trane - BrainBox AI announces a strategic collaboration with Trane - by Trane Technologies. The collaboration paves the way for the companies to create a solution that couples Trane's cloud-based Tracer SC+ building automation system with BrainBox AI's autonomous decarbonizing AI-tech to help Trane customers further reduce greenhouse gas emissions emissions and unlock operational cost savings.

10:06 EDT Magnite announces global partnership with Scope3 - Magnite announced a global partnership with Scope3 to make carbon emissions data available across Magnite's extensive omnichannel inventory. As a result, advertisers will be able to assess their carbon emissions and align their sustainability goals with their campaign performance. "Our partnership with Scope3 is one of the many ways Magnite is incorporating sustainability into our workstreams to help our clients get more insight into their carbon emissions, with the goal of creating a more environmentally-friendly future," said Sean Buckley, Chief Revenue Officer at Magnite. "Digital advertising is inherently an energy-intensive business given the high level of data processing required. We recognize and seek to minimize our environmental impact as the largest independent SSP and want to help our clients do the same. We are working closely with publishers, marketers and our peers to constantly innovate to create more energy efficient practices while also improving advertising outcomes."

10:05 EDT U Power starts install of second UOTTA battery-swapping station - U Power announced that the Company's subsidiary, Youpin Automobile Service Group, pursuant to a strategic cooperation agreement and an equipment procurement contract for the sale and installation of two UOTTA battery-swapping stations, with Zhejiang Petroleum Energy Sales Co., has started the installation for a second station for electric taxis in Anji county, Zhejiang Province. Zhejiang Petroleum is a comprehensive energy integrated supply and service provider owned by China's energy conglomerate, Zhejiang Provincial Energy Group. The second station is expected to be delivered in September and open to the public by October 2023. Jia Li, Chief Executive Officer, and Chairman of the Board of Directors of the Company, commented, "We are excited to further our cooperation with Zhejiang Petroleum to expand our presence in the new energy arena. Zhejiang Province ranks fourth in terms of GDP in China in 2022 and places great emphasis on the green economy, according to the National Bureau of Statistics of China. Zhejiang Petroleum is accelerating its new energy business development and jointly promoting electric vehicle battery swapping services with U Power.."

10:04 EDT Microchip team up with IHWK to develop analog compute platform - Intelligent Hardware Korea, IHWK, is developing a neuromorphic computing platform for neurotechnology devices and field programmable neuromorphic devices. Microchip Technology, via its Silicon Storage Technology subsidiary, is assisting with development of this platform by providing an evaluation system for its SuperFlash memBrain neuromorphic memory solution. The solution is based on Microchip's industry-proven nonvolatile memory SuperFlash technology and is optimized to perform vector matrix multiplication for neural networks through an analog in-memory compute approach.

10:04 EDT LiveOne increases stock buyback from $7.5M-$8.5M - LiveOne (LVO) announced that it has increased its stock repurchase program to a total of approximately $8.5 million worth of LiveOne's shares of common stock, inclusive of the shares that have already been repurchased. The expanded plan may include the possibility of buying back shares of common stock of PodcastOne (PODC). Robert Ellin, LiveOne's CEO and Chairman, commented, "Our confidence in LiveOne's shares being severely undervalued persists, and we remain committed to aggressively repurchasing more shares."

10:03 EDT Adaptive Biotechnologies announces launch of Epic Integration for clonoSEQ - Adaptive Biotechnologies announced that clonoSEQ is now available to health care providers as a fully integrated test in Aura, Epic's specialty diagnostics suite. This integration will allow providers to order and review clonoSEQ minimal residual disease testing results in Epic as they would for any test performed directly at the site of care. Under the partnership established in September 2022, clonoSEQ is available to healthcare providers through Aura, Epic's specialty diagnostics suite.

10:03 EDT SPS Commerce completes acquisition of TIE Kinetix - SPS Commerce announced it has completed the acquisition of TIE Kinetix, a leading provider of supply chain digitalization including EDI and e-invoicing in Europe. "We are pleased to officially welcome TIE Kinetix employees and customers to our growing network of trading partners around the world," said Archie Black, CEO of SPS Commerce. "With the acquisition of TIE Kinetix, we believe SPS Commerce is well positioned to capitalize on the opportunity presented by mandatory e-invoicing regulations across Europe, while expanding our European presence to serve our growing network with access to international markets."

10:02 EDT Marimed introduces new THC-infused blueberry muffin bites - MariMed Inc announces the latest addition to its Bubby's Baked THC-infused soft baked goods line of edibles. They join the popular Bubby's Baked line inspired by the original pot brownie recipe and are available at select dispensaries in Massachusetts, Maryland, and Delaware.

10:02 EDT Mainz Biomed announces topline results from ColoFuture study - Mainz Biomed announced topline results from its ColoFuture study. The ColoFuture study is a multi-center international clinical trial assessing the potential to integrate a portfolio of novel gene expression, or mRNA, biomarkers into ColoAlert, the company's highly efficacious, and screening test for colorectal cancer, or CRC, which is being commercialized across Europe and in select international territories. The results of this groundbreaking study included sensitivity for colorectal cancer of 94% with a specificity of 97% and a sensitivity for advanced adenoma of 81%. The portfolio of mRNA biomarkers evaluated in the ColoFuture study was acquired from the Universite de Sherbrooke to potentially enhance ColoAlert's technical profile to further extend its capability to include the identification of advanced adenomas, or AA, a type of pre-cancerous polyp often attributed to CRC, and to increase the diagnostic sensitivity and specificity rates for CRC. In Sherbrooke's pioneering work, researchers tested a battery of novel transcriptional mRNA biomarkers using samples obtained from patients diagnosed with CRC or as having an advanced adenoma and identified a subset of mRNA biomarkers that provided the greatest sensitivity and specificity of detection. Mainz Biomed specifically selected those mRNA biomarkers which demonstrated not just the ability to detect a disease signal from samples of patients who were known to have colorectal cancer, but also the unique potential to identify a signal from samples of patients with advanced adenomas. The power to detect lesions in a pre-cancerous stage can change the entire CRC diagnostic landscape. If advanced adenomas are identified early, they are curable. By treating the patient before the polyps can progress to a cancerous stage, CRC can be prevented. COLOFUTURE is an international clinical study evaluating the performance of the Mainz Biomed Colorectal Cancer Screening Test. This test is a combination of the ColoAlert test and novel mRNA markers. COLOFUTURE includes subjects aged 40-85 from participating centers in Germany, Norway and Denmark. Subjects are invited to participate in the study either when referred for colonoscopy or if already diagnosed with colorectal adenocarcinoma but treatment-naive. To be included, subjects provide informed consent and submit samples from one stool collection prior to colonoscopy or treatment. Completed subjects are placed into one of the following groups based on the colonoscopy results and any applicable pathology report from biopsy: colorectal adenocarcinoma, advanced precancerous lesions in the colon or rectum, non-advanced adenoma, or normal. Each subject's stool sample is tested with the Mainz Biomed Colorectal Cancer Screening Test. The primary endpoints of the study are to determine sensitivity and specificity for colorectal adenocarcinoma. There are multiple secondary and exploratory endpoints including determining sensitivity and specificity for advanced precancerous lesions in the colon. The interim analysis included 220 subjects.

10:02 EDT Bullfrog AI announces three-year partnership with LBD - BullFrog AI Holdings, Inc. announced a three-year global strategic partnership with the Lieber Institute for Brain Development, LIBD. Under the terms of the agreement, BullFrog AI will leverage its bfLEAP platform to mine LIBD's comprehensive brain data, including transcriptomic, genomic, DNA methylation, cell-line, clinical, and imaging data. The goal of the partnership is to identify previously unrecognized relationships between genes and pathways in the brain and the development of neurologic and psychiatric disorders, thereby facilitating the development of more effective treatments for diseases of the human brain. The partnership includes a one-year term of data exclusivity to complete the first stages of analyses, with a two-year extension option as performance milestones are met. Throughout the collaboration, BullFrog AI will receive access to LIBD's collection of brain data for further analyses and additional research projects.

10:00 EDT Climb Global's Climb Channel Solutions launches partnership with GigaIO - Climb Channel Solutions, a wholly owned subsidiary of Climb Global Solutions has announced a strategic partnership with GigaIO, a pioneer in AI and high-performance data center infrastructure solutions. This collaboration represents a significant step forward in Climb's data center connectivity offerings and promises to deliver cutting-edge solutions to the channel to optimize their customers' data center operations. "We are proud to partner with GigaIO, a company recognized for its innovative contributions to the data center industry and edge computing," says Dale Foster, CEO of Climb Channel Solutions. "As we are both focused on agility, flexibility and scalability, this partnership aligns with our core mission of providing the channel with the best in emerging technologies and expanding our offerings throughout a range of technology categories."

10:00 EDT WeWork falls -15.8% - WeWork is down -15.8%, or -91c to $4.83.

10:00 EDT Amprius Technologies rises 8.1% - Amprius Technologies is up 8.1%, or 33c to $4.37.

10:00 EDT HireRight rises 13.5% - HireRight is up 13.5%, or $1.18 to $9.93.

09:56 EDT Thermo Fisher, Devyser enter agreement to promote laborator services - Devyser and Thermo Fisher Scientific have entered into a collaboration agreement to promote laboratory services. The goal is to partner with pharmaceutical companies to support their development projects utilizing Devyser's unique assays in its CLIA-certified laboratory. The companies will work together to promote the Devyser laboratory services to support and advance research and development for pharmaceutical companies.

09:56 EDT Cineverse promotes Mark Lindsey to CFO - Cineverse Corp. announced the appointment of Mark Lindsey as CFO, effective September 14, 2023. Lindsey has served as Executive Vice President, Accounting and Finance, at Cineverse since November 2022. As CFO, Lindsey will lead Cineverse's global finance and accounting teams, overseeing financial planning, accounting, capital markets, strategy, and cost-streaming initiatives.

09:54 EDT Philip Morris raises quarterly dividend 2.4% to $1.30 from $1.27 per share - The Board of Directors of Philip Morris International has increased the company's regular quarterly dividend by 2.4% to an annualized rate of $5.20 per share. The new quarterly dividend of $1.30 per share, up from $1.27 per share, is payable on October 12 to shareholders of record as of September 27. The ex-dividend date is September 26.